GO:0032745 positive regulation of interleukin-21 production: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032745 describes any process that activates or increases the frequency, rate, or extent of interleukin-21 (IL-21) production.
• IL-21 is a pleiotropic cytokine produced mainly by CD4+ T cells, including T follicular helper (Tfh) and Th17 cells, and is critical for germinal center formation and humoral immunity.
• Positive regulation of IL-21 production involves TCR signaling, costimulation, and autocrine loops that amplify IL-21 expression in activated T cells.
• Dysregulated IL-21 production is linked to autoimmune diseases such as celiac disease, inflammatory bowel disease, and colitis-associated colon cancer [3,6,7,8].
• IL-21 also plays a role in viral infections, where it can enhance antiviral immunity but may also contribute to immunopathology.
• CRISPR-based models (knockout, knock-in, overexpression) are essential for dissecting the genetic and molecular regulators of IL-21 production [1,4].
Description
Interleukin-21 (IL-21) is a type I cytokine that belongs to the common gamma-chain family and is predominantly produced by activated CD4+ T cells, particularly T follicular helper (Tfh) and Th17 cells. The Gene Ontology term GO:0032745, positive regulation of interleukin-21 production, encompasses all molecular events that enhance the synthesis and secretion of IL-21. This process is central to the coordination of humoral immunity, as IL-21 drives B cell differentiation, germinal center formation, and antibody production. Understanding how IL-21 production is positively regulated is therefore critical for immunology research and for developing therapies against autoimmune diseases and cancers. The regulation of IL-21 production is tightly controlled at multiple levels, including transcriptional activation, post-transcriptional modifications, and autocrine feedback loops. Dysregulation of this process has been implicated in a range of pathological conditions, from celiac disease to colitis-associated colon cancer [3,7]. This article provides a comprehensive overview of GO:0032745, integrating authoritative GO definitions with published literature to guide researchers in studying this important biological process.
positive regulation of interleukin-21 production At A Glance
| GO ID | GO:0032745 |
|---|---|
| GO term | positive regulation of interleukin-21 production |
| Ontology | biological_process |
| Synonym | activation of interleukin-21 production; positive regulation of IL-21 production; positive regulation of interleukin-21 biosynthetic process; stimulation of interleukin-21 production; up regulation of interleukin-21 production; up-regulation of interleukin-21 production; upregulation of interleukin-21 production |
| Major function | Enhances the production of interleukin-21, a cytokine critical for germinal center formation, B cell differentiation, and Th17 responses. |
| Related cytokines | IL-21, IL-6, IL-23, TGF-beta, IL-2, IL-15 [4,6] |
| Key cell types | CD4+ T cells (Tfh, Th17), NKT cells, and some innate lymphoid cells [1,6] |
| Associated diseases | Celiac disease, inflammatory bowel disease, colitis-associated colon cancer, autoimmune diseases [3,6,7,8] |
What Is GO:0032745?
GO:0032745, positive regulation of interleukin-21 production, is defined as any process that activates or increases the frequency, rate, or extent of interleukin-21 production. This biological process includes the upstream signaling events, transcriptional activation, and post-transcriptional mechanisms that lead to increased IL-21 synthesis and secretion. It is a child of the broader terms 'regulation of interleukin-21 production' and 'positive regulation of cytokine production'.
Why Is positive regulation of interleukin-21 production Important in Cell Biology?
Positive regulation of IL-21 production is a cornerstone of adaptive immunity, as IL-21 is essential for the germinal center reaction, affinity maturation, and the generation of high-affinity antibodies. Moreover, IL-21 is a key effector cytokine in Th17-mediated inflammation, and its overproduction contributes to the pathogenesis of autoimmune and inflammatory diseases [6,8]. Conversely, IL-21 has potent antitumor effects in some contexts, making its regulation a double-edged sword in cancer immunology [3,5]. Understanding the molecular mechanisms that positively regulate IL-21 production is therefore crucial for designing targeted immunotherapies and for interpreting disease-associated genetic variants.
• IL-21 is required for germinal center formation and Tfh cell function, directly influencing vaccine responses and humoral immunity.
• Positive regulation of IL-21 production is a hallmark of Th17 cell differentiation and is implicated in autoimmune diseases such as psoriasis and rheumatoid arthritis [6,8].
• In celiac disease, increased IL-21 production in the small intestine contributes to mucosal inflammation and tissue damage.
• IL-21 has been linked to colitis-associated colon cancer, where it can promote tumorigenesis through chronic inflammation.
• IL-21 enhances the cytotoxic activity of CD8+ T cells and NK cells, making it a candidate for cancer immunotherapy [2,5].
• Dysregulated IL-21 production is observed in viral infections, where it may either protect against or exacerbate disease.
• The autocrine regulation of IL-21 production in T cells highlights the importance of positive feedback loops in sustaining immune responses.
• Genetic variants in IL21 and its receptor have been associated with susceptibility to autoimmune and inflammatory disorders.
• Understanding positive regulation of IL-21 production can inform the development of IL-21-based therapeutics and inhibitors.
• CRISPR screening and knockout models are powerful tools to identify novel regulators of IL-21 production [1,4].
What Happens During positive regulation of interleukin-21 production?
T cell receptor (TCR) and costimulatory signaling
In simple terms: When a T cell recognizes an antigen, it receives signals that turn on genes, including IL-21.
Positive regulation of IL-21 production is initiated by T cell receptor (TCR) engagement and costimulation through CD28. These signals activate downstream transcription factors such as NFAT, NF-kB, and AP-1, which bind to the IL21 promoter and enhance transcription. In Tfh cells, sustained TCR signaling and ICOS costimulation are particularly important for high IL-21 production.
Cytokine-driven amplification
In simple terms: Other cytokines, like IL-6 and IL-23, can boost the production of IL-21.
Cytokines such as IL-6, IL-23, and IL-1beta synergize with TCR signals to further increase IL-21 production. For example, IL-6 activates STAT3, which directly binds to the IL21 promoter and enhances its transcription. IL-23, produced by dendritic cells, promotes Th17 cell differentiation and sustains IL-21 expression, creating a positive feedback loop.
Autocrine feedback loop
In simple terms: IL-21 can stimulate its own production in T cells, creating a self-amplifying cycle.
IL-21 produced by activated T cells can bind to the IL-21 receptor on the same cell or neighboring T cells, activating STAT3 and further enhancing IL-21 transcription. This autocrine positive feedback loop is critical for sustaining IL-21 production and has been demonstrated in human T lymphocytes.
Transcriptional and epigenetic regulation
In simple terms: The IL21 gene can be turned on or off by changes in DNA packaging and transcription factor binding.
The IL21 locus undergoes epigenetic modifications, including histone acetylation and DNA demethylation, that facilitate transcription. Transcription factors such as c-Maf, BATF, and IRF4 are essential for IL-21 production in Tfh and Th17 cells. Their cooperative binding to the IL21 promoter and enhancer regions drives robust IL-21 expression.
Post-transcriptional regulation
In simple terms: After the gene is transcribed, the RNA message can be stabilized or degraded to control how much IL-21 is made.
MicroRNAs and RNA-binding proteins can modulate IL-21 production by affecting mRNA stability or translation. For instance, miR-21 has been shown to indirectly promote IL-21 production in T cells by targeting negative regulators. Additionally, AU-rich elements in the 3' untranslated region of IL21 mRNA can influence its half-life.
Key Genes Involved in GO:0032745 positive regulation of interleukin-21 production
The following genes and proteins are key players in the positive regulation of interleukin-21 production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL21 | Encodes interleukin-21 cytokine | Central to the process; knockout and overexpression models are used to study its function. |
| IL21R | IL-21 receptor | Mediates autocrine and paracrine signaling; mutations affect IL-21 responsiveness. |
| STAT3 | Transcription factor downstream of IL-6 and IL-21 | Directly activates IL21 transcription; knockout reduces IL-21 production. |
| NFATC2 | Transcription factor activated by TCR signaling | Binds IL21 promoter; regulates IL-21 production in T cells. |
| NFKB1 | Transcription factor in canonical NF-kB pathway | Enhances IL21 transcription upon TCR costimulation. |
| MAF | Transcription factor c-Maf | Critical for IL-21 production in Tfh and Th17 cells. |
| BATF | Transcription factor | Cooperates with IRF4 to drive IL-21 expression. |
| IRF4 | Interferon regulatory factor 4 | Essential for Tfh cell IL-21 production. |
| IL6 | Pro-inflammatory cytokine | Induces STAT3 activation and enhances IL-21 production. |
| IL23A | Subunit of IL-23 cytokine | Promotes Th17 differentiation and IL-21 production. |
| ICOS | Costimulatory molecule | Enhances IL-21 production in Tfh cells. |
| CD28 | Costimulatory receptor | Provides signals that amplify IL-21 transcription. |
| PRDM1 | Transcription factor Blimp-1 | Regulates IL-21 production in T cells. |
| TOX | Transcription factor | Required for Tfh cell development and IL-21 production. |
| BCL6 | Transcription factor | Master regulator of Tfh cells; promotes IL-21 expression. |
| MIR21 | MicroRNA-21 | Indirectly enhances IL-21 production by targeting negative regulators. |
| IL2 | T cell growth factor | Can enhance IL-21 production in activated T cells. |
| IL15 | Cytokine | Synergizes with IL-21 to promote T cell responses. |
How Is positive regulation of interleukin-21 production Regulated?
The positive regulation of IL-21 production is controlled by a complex network of signaling pathways and transcription factors. Key regulators include STAT3, which is activated by IL-6 and IL-21 itself, and the transcription factors c-Maf, BATF, and IRF4, which are essential for IL-21 expression in Tfh and Th17 cells [1,6]. Additionally, costimulatory molecules such as ICOS and CD28 amplify TCR-induced IL-21 production. Epigenetic modifications, including histone acetylation and DNA demethylation at the IL21 locus, also play a role in sustaining high levels of IL-21 production. Negative regulators, such as Blimp-1, can dampen IL-21 expression to prevent excessive inflammation.
positive regulation of interleukin-21 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL21 | Celiac disease, IBD, colitis-associated colon cancer | Knockout mice, human T cell lines with CRISPR knockout [3,6,7] |
| STAT3 | Autoimmune diseases, cancer | Point mutation knock-in mice (e.g., STAT3 hypermorphic) |
| IL21R | Immunodeficiency, autoimmunity | Knockout mice, patient-derived cells |
| IL6 | Inflammatory diseases, cytokine storm | Overexpression models, knockout mice |
| IL23A | Psoriasis, IBD | Knock-in mice, human organoids |
IL-21 in autoimmune and inflammatory diseases
Dysregulated positive regulation of IL-21 production is a hallmark of several autoimmune diseases. In celiac disease, increased IL-21 production in the small intestine contributes to mucosal inflammation and villous atrophy. Similarly, in inflammatory bowel disease (IBD), elevated IL-21 levels exacerbate gut inflammation by promoting Th17 responses. IL-21 also plays a pathogenic role in rheumatoid arthritis and psoriasis, where it drives Th17 cell differentiation and pro-inflammatory cytokine production.
IL-21 in cancer
The role of IL-21 in cancer is context-dependent. In colitis-associated colon cancer, IL-21 produced by T cells promotes tumorigenesis through chronic inflammation and STAT3 activation. Conversely, IL-21 has potent antitumor effects in melanoma and other cancers by enhancing CD8+ T cell and NK cell cytotoxicity. Therefore, positive regulation of IL-21 production can be either beneficial or detrimental depending on the tumor type and microenvironment.
IL-21 in viral infections
IL-21 is induced during viral infections and can enhance antiviral T cell and B cell responses. However, excessive IL-21 production may contribute to immunopathology in chronic viral infections. For example, in HIV infection, IL-21 levels correlate with viral control, but sustained IL-21 production can also drive immune activation.
From positive regulation of interleukin-21 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IL-21 production? | CRISPR knockout in primary human T cells or Jurkat cells |
| Does a specific mutation in STAT3 affect IL-21 production? | Point mutation knock-in via CRISPR in T cell lines |
| Can we tag endogenous IL-21 for live tracking? | Knock-in of fluorescent reporter (e.g., GFP) at IL21 locus |
| What is the effect of IL-21 overexpression in vivo? | Transgenic or CRISPR-mediated overexpression in mice |
| Which genes are essential for IL-21 production? | Genome-wide CRISPR library screening in T cells |
| How does IL-21 autocrine signaling affect T cell differentiation? | Knockout of IL21R in primary T cells |
How to Study the positive regulation of interleukin-21 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on IL-21 production | Identify novel positive regulators |
| RNA-seq | Transcriptional changes | Discover signaling pathways and networks |
| Flow cytometry | Intracellular IL-21 and surface markers | Quantify IL-21+ cell frequencies |
| ELISA | Secreted IL-21 protein levels | Validate knockout/overexpression effects |
| Western blot | STAT3 phosphorylation and other signaling proteins | Confirm pathway activation |
| ChIP-seq | Transcription factor binding at IL21 locus | Map regulatory elements |
| ATAC-seq | Chromatin accessibility | Assess epigenetic regulation |
| CRISPR activation (CRISPRa) | Gain-of-function effects on IL-21 production | Identify enhancers and activators |
CRISPR knockout screening
Genome-wide CRISPR knockout screens in primary human T cells or Jurkat cells can identify novel regulators of IL-21 production. Cells are stimulated through the TCR, and IL-21 secretion is measured by ELISA or flow cytometry. Guide RNAs targeting candidate genes are enriched or depleted based on their effect on IL-21 levels.
Transcriptional profiling (RNA-seq)
RNA sequencing of T cells under conditions that induce IL-21 production can reveal transcriptional networks and signaling pathways that positively regulate IL21 expression. Comparing wild-type and knockout cells identifies genes whose expression correlates with IL-21 levels.
Flow cytometry and intracellular cytokine staining
Flow cytometry allows simultaneous measurement of IL-21 production and surface markers in single cells. Intracellular staining for IL-21 after brief stimulation enables identification of IL-21-producing cell subsets and quantification of positive regulation.
ELISA and cytokine bead arrays
ELISA and multiplex cytokine assays quantify secreted IL-21 in culture supernatants. These methods are used to validate CRISPR knockout or overexpression effects on IL-21 production.
How CRISPR Can Be Used to Study GO:0032745 positive regulation of interleukin-21 production
Knockout
CRISPR knockout of candidate genes in T cell lines or primary T cells is used to determine whether a gene is required for IL-21 production. For example, knockout of STAT3 or BATF abolishes IL-21 production upon TCR stimulation [1,6]. Knockout models are also valuable for validating hits from genome-wide screens.
Point Mutation
Point mutations can be introduced via CRISPR to model disease-associated variants or to dissect specific phosphorylation sites. For instance, knock-in of a STAT3 mutation that affects its DNA-binding activity can reveal its role in IL-21 regulation.
Knock-in
Knock-in of reporter genes (e.g., GFP) at the IL21 locus allows real-time tracking of IL-21-producing cells. Alternatively, knock-in of epitope tags enables chromatin immunoprecipitation or proteomic studies.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPRa) or lentiviral overexpression of candidate genes can test whether a gene is sufficient to enhance IL-21 production. This approach is useful for studying gain-of-function mechanisms in autoimmune diseases.
How EDITGENE Supports positive regulation of interleukin-21 production Research
Researchers studying positive regulation of interleukin-21 production-related genes often need to determine whether a candidate gene is causally involved in IL-21 regulation or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interleukin-21 production research.
Frequently Asked Questions About positive regulation of interleukin-21 production
What is GO:0032745?
GO:0032745 is the Gene Ontology term for positive regulation of interleukin-21 production, defined as any process that activates or increases the frequency, rate, or extent of IL-21 production.
What genes are involved in positive regulation of interleukin-21 production?
Key genes include IL21, IL21R, STAT3, NFATC2, NFKB1, MAF, BATF, IRF4, IL6, IL23A, ICOS, CD28, PRDM1, TOX, BCL6, and MIR21 [1,4,6,8].
How is IL-21 production regulated in T cells?
IL-21 production is regulated by TCR signaling, costimulation, cytokines such as IL-6 and IL-23, and transcription factors like STAT3, c-Maf, BATF, and IRF4. Autocrine feedback also amplifies IL-21 production [1,4,6].
What diseases are associated with dysregulated IL-21 production?
Dysregulated IL-21 production is linked to celiac disease, inflammatory bowel disease, colitis-associated colon cancer, rheumatoid arthritis, psoriasis, and certain viral infections [2,3,6,7,8].
What is the role of IL-21 in germinal center formation?
IL-21 produced by Tfh cells is essential for germinal center formation, B cell differentiation, and antibody production.
How can CRISPR be used to study IL-21 regulation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in IL-21 production [1,4].
What is the autocrine regulation of IL-21 production?
Autocrine regulation refers to IL-21 binding to its receptor on the same cell, activating STAT3 and further enhancing IL-21 transcription, creating a positive feedback loop.
Which transcription factors are critical for IL-21 production?
STAT3, NFAT, NF-kB, c-Maf, BATF, and IRF4 are critical transcription factors that bind to the IL21 promoter and enhance its expression [1,4,6].
Is IL-21 production increased in celiac disease?
Yes, studies have shown increased IL-21 production in the small intestine of pediatric celiac disease patients, contributing to mucosal inflammation.
What methods are used to measure IL-21 production?
ELISA, flow cytometry, intracellular cytokine staining, RNA-seq, and CRISPR screens are commonly used to measure and study IL-21 production [1,4].
Conclusion
GO:0032745, positive regulation of interleukin-21 production, is a critical biological process that governs the immune response by controlling the levels of IL-21, a cytokine with pleiotropic functions in germinal center formation, Th17 differentiation, and antiviral immunity. Dysregulation of this process contributes to autoimmune diseases, inflammatory disorders, and cancer, making it a target of intense research. Advances in CRISPR-based gene editing and screening technologies are enabling researchers to dissect the complex regulatory networks that control IL-21 production. EDITGENE provides comprehensive CRISPR services to support these efforts, from knockout and knock-in models to library screening and bioinformatics analysis.
References
- 1. Tangye SG et al.. 2020. Regulation of the germinal center and humoral immunity by interleukin-21.. J Exp Med 217(1) PMID: 31821441
- 2. Asao H. 2021. Interleukin-21 in Viral Infections.. Int J Mol Sci 22(17) PMID: 34502427
- 3. Stolfi C et al.. 2011. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.. J Exp Med 208(11):2279-90 PMID: 21987656
- 4. Caprioli F et al.. 2008. Autocrine regulation of IL-21 production in human T lymphocytes.. J Immunol 180(3):1800-7 PMID: 18209077
- 5. Spolski R et al.. 2008. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer.. Curr Opin Immunol 20(3):295-301 PMID: 18554883
- 6. Fina D et al.. 2008. Regulation of gut inflammation and th17 cell response by interleukin-21.. Gastroenterology 134(4):1038-48 PMID: 18395085
- 7. van Leeuwen MA et al.. 2013. Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease.. Mucosal Immunol 6(6):1202-13 PMID: 23571506
- 8. Long D et al.. 2019. Clinical significance and immunobiology of IL-21 in autoimmunity.. J Autoimmun 99:1-14 PMID: 30773373
